Supriya Lifescience Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SUPRIYA.NS | UNC.F | CONCORDBIO.NS | 1777.TWO | 688177.SS | 18H0.F | |
|---|---|---|---|---|---|---|
| Market cap | 69.99B | 54.28B | 140.75B | 3.44B | 7.38B | 5.11M |
| P/E (TTM) | 35.3 | 25.2 | 50.4 | 10.4 | — | — |
| Forward P/E | 22.4 | — | 32.5 | — | -26.2 | — |
| Price/book | 5.8 | 4.7 | 6.9 | 1.3 | 171.3 | -1.1 |
| Dividend yield | 0.12% | 0.53% | 0.58% | 5.17% | — | — |
| 1-year change | +10.34% | +28.54% | −7.11% | −1.15% | −34.43% | −25.00% |
| Today | +1.13% | +3.11% | +2.62% | −0.26% | +2.95% | −23.81% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All SUPRIYA.NS news ›Supriya Lifescience receives 'Strong' rating from CRISIL ESG Ratings & Analytics
Supriya Lifescience Limited, a government recognised export house headquartered in Mumbai, has been awarded an 'ESG 65' rating in the 'Strong' category by CRISIL ESG Ratings & Analytics Limited. This recognition underscores the company's…
Supriya Lifescience NSE:SUPRIYA Reg 74(5) Compliance Certificate Q2 FY27
Kalkine India Supriya Lifescience (NSE:SUPRIYA): What Does the Reg 74(5) Certificate Mean for Shareholders? Source: Krish Capital Pty Ltd Supriya Lifescience Limited (NSE:SUPRIYA) submitted to the National Stock Exchange of In
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- businessupturn.com1
- kalkine.co.in1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.